CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 67 filers reported holding CULLINAN ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,508,000 | -72.0% | 429,646 | -72.0% | 0.10% | -67.4% |
| Q2 2022 | $19,686,000 | +22.4% | 1,535,560 | 0.0% | 0.29% | +68.2% |
| Q1 2022 | $16,077,000 | -28.6% | 1,535,560 | 0.0% | 0.17% | -22.1% |
| Q4 2021 | $22,509,000 | -44.1% | 1,535,560 | -16.3% | 0.22% | -40.0% |
| Q3 2021 | $40,237,000 | -13.1% | 1,835,560 | 0.0% | 0.37% | -1.3% |
| Q2 2021 | $46,277,000 | -35.5% | 1,835,560 | 0.0% | 0.38% | -34.3% |
| Q1 2021 | $71,699,000 | – | 1,835,560 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $98,051,000 | 27.24% |
| CHI Advisors LLC | 3,047,609 | $39,070,000 | 14.92% |
| Nextech Invest Ltd. | 1,221,145 | $15,655,000 | 5.28% |
| BVF INC/IL | 7,509,059 | $96,266,000 | 4.65% |
| TANG CAPITAL MANAGEMENT LLC | 609,231 | $7,810,000 | 1.18% |
| Boxer Capital, LLC | 1,074,082 | $13,770,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 213,090 | $2,732,000 | 0.84% |
| Atom Investors LP | 96,880 | $1,242,000 | 0.54% |
| EcoR1 Capital, LLC | 1,169,889 | $14,998,000 | 0.52% |
| Birchview Capital, LP | 45,114 | $578,000 | 0.42% |